.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Rise (MI) concentrated over one-third of sales in Concentrates at 35.0% share while ranking 45th in Michigan Concentrates, with that category down 44.9% year over year and 10.4% month over month; this anchor category carried a lower average price of $15.95 versus the brand’s overall $17.01 average, indicating price-sensitive volume. Topical rose to 24.9% mix with an 11.4% month-over-month lift despite a 57.5% year-over-year decline, while Tincture & Sublingual held 21.5% share with a 3.8% month-over-month dip and 48.7% year-over-year drop; Capsules maintained 18.5% mix with the smallest year-over-year decline at 2.7% but slipped 6.0% month over month. The combination of a month-over-month rebound in Topical alongside double-digit month-over-month contraction in Concentrates implies the brand is rotating demand from inhalable potency toward wellness formats without offsetting the broader 45.4% year-over-year brand sales decline.
With Concentrates still the largest slice at 35.0% but eroding 10.4% month over month as Topical gained 11.4% month over month to nearly one-quarter of sales, positioning is tilting toward non-inhalable relief and value tiers where average prices sit at $21.01 in Topical versus $15.95 in Concentrates. Capsules’ minimal 2.7% year-over-year decline contrasted with deeper double-digit declines in Tincture & Sublingual (48.7%) and Concentrates (44.9%) suggests defensibility in dose-controlled formats, yet the 6.0% month-over-month Capsules dip and 3.8% month-over-month Tincture & Sublingual dip signal near-term pressure that the 11.4% Topical uptick cannot fully counter. The pattern implies Rise (MI) should treat Topical and Capsules as retention pillars while addressing Concentrates price and rank pressure at 45th in Michigan to stabilize mix and mitigate the 3.8% average price decline year over year.
Competitive Landscape
Rise (MI) sits at rank #45 in MI Concentrates in May 2026, down 17 positions year over year from #28 and up 14 positions from #59 in February 2026, while still trailing its peak at #21 from December 2024 by 24 spots; in contrast, Rkive Cannabis advanced to #1 from #6 year over year with 218.3% sales growth, and The Limit edged from #1 to #2 as Wojo Co climbed from #4 to #3 with 15.1% growth. Given that Cannalicious Labs holds #5 despite a -30.7% sales change and The Fresh Canna moved from #9 to #4 with 39.5% growth, Rise (MI)’s year-over-year drop alongside a recent quarter-on-quarter rebound implies momentum is recovering off a lower base but will require share capture against faster-rising leaders to re-approach prior peak positioning.
Notable Products
CBD Tablets 30-Pack (1500mg CBD) posted the steepest decline in May 2026 at -35.3%, sliding to rank 8, while CBN/CBD/ THC 1:1:1 PM Evening Tincture (200mg CBN, 200mg CBD, 200mg THC, 30ml) dropped -27.9% to rank 7, indicating demand is softening for sleep-oriented and CBD-heavy formats. In contrast, RSO Tablets 10-Pack (200mg) rose +11.8% to rank 3 as Unscented RSO Cream (1000mg THC, 1oz) in rank 1 added +7.3%, and three of the top seven are Tincture & Sublingual SKUs, pointing to a portfolio still anchored in ingestibles even as certain sublines fade. Hybrid RSO Dart (1g) slipped -6.2% at rank 2, narrowing the gap with tablet-based RSO, and the product mix concentrates share of top spots around RSO-led therapies more than inhalables. The pattern implies Rise (MI) is consolidating around RSO formats and core ingestibles, with wellness-positioned CBD/CBN items retrenching despite a roughly $10.98k lead SKU in Topical.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
